The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom

Short-term costs of integrating whole-genome sequencing into primary care and cardiology settings: a pilot randomized trial

(2018) Kurt D Christensen et al.   GENETICS IN MEDICINE

Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature

(2018) Katharina Schwarze et al.   GENETICS IN MEDICINE

A microcosting and cost–consequence analysis of clinical genomic testing strategies in autism spectrum disorder

(2017) Kate Tsiplova et al.   GENETICS IN MEDICINE

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer

(2017) Marilyn M. Li et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers

(2017) Deirdre Weymann et al.   Molecular Genetics & Genomic Medicine

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics

(2016) Sarah S. Kalia et al.   GENETICS IN MEDICINE

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

Factors influencing success of clinical genome sequencing across a broad spectrum of disorders

(2015) Jenny C Taylor et al.   NATURE GENETICS

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

(2013) Robert C. Green et al.   GENETICS IN MEDICINE

Issues surrounding the health economic evaluation of genomic technologies

(2013) James Buchanan et al.   PHARMACOGENOMICS

The $1,000 genome, the $100,000 analysis?

(2010) Elaine R Mardis   Genome Medicine